Aging Neurosci
Infection signs: Increasing redness, warmth, swelling, and tenderness over 24-48 hours after injection, especially if accompanied by fever or pus at the site, suggest infection
Semaglutide is a GLP-1 receptor agonist, primarily used to treat type 2 diabetes and obesity
Signs include widespread hives (not just at the injection site), difficulty breathing, swelling of the face or throat, rapid heartbeat, or severe dizziness
Originally developed for type 2 diabetes, these drugs have now proven to be some of the most powerful tools for sustainable weight loss
declares having received honoraria from Novo Nordisk, Eli Lilly, Akebia Therapeutics, Ardelyx, Becton Dickinson, Endologix, FibroGen, GSK, Medtronic, Neovasc, Provention Bio, ReCor, BrainStorm Cell Therapeutics, Alnylam and Intarcia for consulting activities, and research funding to his institution from AbbVie, Esperion, AstraZeneca, CSL Behring, Novartis and Eli Lilly